Viewing nowBarostat 40 mg Tablet (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 43.38mg
Tablet · Prescription medication
Samik Pharmaceutical Co., Ltd.

MFDS item code 201906327 · Approved 2019.09.05 · Insurance code 644004340
Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication helps reduce the risk of myocardial infarction, stroke, and vascular invasive procedures in adults with various risk factors for cardiovascular disease and in patients with diabetes. Additionally, it reduces the risk of hospitalization due to myocardial infarction, stroke, angina, and congestive heart failure in patients with heart disease. Furthermore, it is used to reduce total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels while increasing HDL cholesterol in patients with hyperlipidemia, thereby improving blood lipid levels. This drug is also effectively used as an adjunct in various types of dyslipidemia that do not respond well to dietary changes. Thus, this medication is used beneficially to maintain cardiovascular health and manage hyperlipidemia.
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into consideration the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose should be adjusted accordingly. As the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not possible. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years or older are generally similar to those in adult patients.
This medication can affect the muscles; therefore, if there are severe muscle pain or weakness, or if muscle enzyme levels significantly increase, discontinue use immediately and consult a doctor. This drug should not be used in individuals with certain liver diseases or those with significantly elevated liver enzyme levels, or in those with muscle disorders. This medication is not given to pregnant women, those who may become pregnant, nursing mothers, or children under 10 years of age. Since this medication can affect liver function, regular liver function tests should be performed before and during treatment, and if symptoms of hepatitis or jaundice occur, the doctor should be notified immediately. Patients who consume a lot of alcohol or have a history of liver disease should use this medication cautiously. Increased plasma concentrations of this drug can heighten the risk of muscle damage; therefore, careful consideration is needed when taken with certain antibiotics, antifungals, or antivirals. It is advisable to avoid grapefruit juice during treatment, and to consult a doctor or pharmacist when taking this drug along with other medications. If symptoms such as muscle pain, weakness, or fever occur during treatment, notify a doctor immediately for evaluation. Elderly patients or those with reduced kidney function are at a higher risk of muscle damage, so careful observation is required during use. Women of childbearing age should use appropriate contraceptive methods while taking this drug, and if pregnancy is confirmed, the medication should be discontinued immediately. This medication is not recommended for nursing women, and breastfeeding should be discontinued during treatment. There is no specific antidote for overdose; therefore, treatment is symptomatic, and liver function and muscle enzyme tests should be conducted. This medication should be kept out of reach of children and stored in its original container to prevent deterioration.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent air or moisture from entering. It is also important to keep it at room temperature, between 1 to 30 degrees Celsius, avoiding extremely hot or cold places.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 43.38mg
Tablet · Prescription medication
Samik Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.